術前にプロトロンビン複合体製剤の予防投与を行ったProthrombin Himiの1例

研究成果: ジャーナルへの寄稿学術論文査読

抄録

Dysprothrombinemia is the rarest inherited bleeding disorder that is characterized by a decrease in the prothrombin activity, but normal antigen levels. In this study, we report the case of a compound heterozygote of two mutations in prothrombin; Met337Thr and Arg388His, which has previously been identified as "Prothrombin Himi." A systemic blood coagulation evaluation revealed a prolonged prothrombin time (39%) and activated partial thromboplastin (64.4 sec), with an isolated severe decrease in the prothrombin activity (8.6%). Preoperative replacement of prothrombin with prothrombin complex concentrate, PPSB-HT "Nichiyaku," successfully prevented abnormal postoperative bleeding after laparoscopic hysterectomy for cervical cancer. This is the second reported case of Prothrombin Himi.

寄稿の翻訳タイトルSuccessful preoperative replacement of prothrombin with prothrombin complex concentrate for Prothrombin Himi
本文言語日本
ページ(範囲)1412-1414
ページ数3
ジャーナル[Rinshō ketsueki] The Japanese journal of clinical hematology
62
9
DOI
出版ステータス出版済み - 2021
外部発表はい

キーワード

  • Blood Coagulation Factors
  • Humans
  • Prothrombin

フィンガープリント

「術前にプロトロンビン複合体製剤の予防投与を行ったProthrombin Himiの1例」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル